Indeed, platelets can interfere with the NKG2D/NKG2DL axis by inducing either the TGF-β-mediated downregulation of NKG2D on NK cells or the shedding of NKG2D ligands from tumor cells [89,90] (Figure 2A). Here, KLRK1 is linked to neoplasm.